Early or late administration of Nirmatrelvir/ritonavir in mild COVID-19 patients with clinical comorbidities: A propensity score-matched territory-wide study

Bibliographic Details
Main Authors: Shuang Liu, Xuan Shen, Fen Zhang, Xiaoqian Shi, Bing Li, Jinfang Xu, Congrong Wang
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Travel Medicine and Infectious Disease
Online Access:http://www.sciencedirect.com/science/article/pii/S1477893923001163
_version_ 1797398691384918016
author Shuang Liu
Xuan Shen
Fen Zhang
Xiaoqian Shi
Bing Li
Jinfang Xu
Congrong Wang
author_facet Shuang Liu
Xuan Shen
Fen Zhang
Xiaoqian Shi
Bing Li
Jinfang Xu
Congrong Wang
author_sort Shuang Liu
collection DOAJ
first_indexed 2024-03-09T01:29:09Z
format Article
id doaj.art-2c036b9fba5f4ad89bd5e39c4b27b439
institution Directory Open Access Journal
issn 1873-0442
language English
last_indexed 2024-03-09T01:29:09Z
publishDate 2023-11-01
publisher Elsevier
record_format Article
series Travel Medicine and Infectious Disease
spelling doaj.art-2c036b9fba5f4ad89bd5e39c4b27b4392023-12-10T06:13:59ZengElsevierTravel Medicine and Infectious Disease1873-04422023-11-0156102656Early or late administration of Nirmatrelvir/ritonavir in mild COVID-19 patients with clinical comorbidities: A propensity score-matched territory-wide studyShuang Liu0Xuan Shen1Fen Zhang2Xiaoqian Shi3Bing Li4Jinfang Xu5Congrong Wang6Department of Endocrinology & Metabolism, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, ChinaDepartment of Endocrinology & Metabolism, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, ChinaDepartment of Pulmonary and Critical Care Medicine, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, ChinaDepartment of Pulmonary and Critical Care Medicine, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, ChinaDepartment of Pulmonary and Critical Care Medicine, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, ChinaCorresponding author. Department of Health Statistics, Naval Medical University, Shanghai, 200433, China.; Department of Health Statistics, Naval Medical University, Shanghai, 200433, ChinaCorresponding author. 1279 Sanmen Road, Department of Endocrinology & Metabolism, Shanghai Fourth People's Hospital, School of Medicine. Tongji University, Shanghai 200434, China.; Department of Endocrinology & Metabolism, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, Chinahttp://www.sciencedirect.com/science/article/pii/S1477893923001163
spellingShingle Shuang Liu
Xuan Shen
Fen Zhang
Xiaoqian Shi
Bing Li
Jinfang Xu
Congrong Wang
Early or late administration of Nirmatrelvir/ritonavir in mild COVID-19 patients with clinical comorbidities: A propensity score-matched territory-wide study
Travel Medicine and Infectious Disease
title Early or late administration of Nirmatrelvir/ritonavir in mild COVID-19 patients with clinical comorbidities: A propensity score-matched territory-wide study
title_full Early or late administration of Nirmatrelvir/ritonavir in mild COVID-19 patients with clinical comorbidities: A propensity score-matched territory-wide study
title_fullStr Early or late administration of Nirmatrelvir/ritonavir in mild COVID-19 patients with clinical comorbidities: A propensity score-matched territory-wide study
title_full_unstemmed Early or late administration of Nirmatrelvir/ritonavir in mild COVID-19 patients with clinical comorbidities: A propensity score-matched territory-wide study
title_short Early or late administration of Nirmatrelvir/ritonavir in mild COVID-19 patients with clinical comorbidities: A propensity score-matched territory-wide study
title_sort early or late administration of nirmatrelvir ritonavir in mild covid 19 patients with clinical comorbidities a propensity score matched territory wide study
url http://www.sciencedirect.com/science/article/pii/S1477893923001163
work_keys_str_mv AT shuangliu earlyorlateadministrationofnirmatrelvirritonavirinmildcovid19patientswithclinicalcomorbiditiesapropensityscorematchedterritorywidestudy
AT xuanshen earlyorlateadministrationofnirmatrelvirritonavirinmildcovid19patientswithclinicalcomorbiditiesapropensityscorematchedterritorywidestudy
AT fenzhang earlyorlateadministrationofnirmatrelvirritonavirinmildcovid19patientswithclinicalcomorbiditiesapropensityscorematchedterritorywidestudy
AT xiaoqianshi earlyorlateadministrationofnirmatrelvirritonavirinmildcovid19patientswithclinicalcomorbiditiesapropensityscorematchedterritorywidestudy
AT bingli earlyorlateadministrationofnirmatrelvirritonavirinmildcovid19patientswithclinicalcomorbiditiesapropensityscorematchedterritorywidestudy
AT jinfangxu earlyorlateadministrationofnirmatrelvirritonavirinmildcovid19patientswithclinicalcomorbiditiesapropensityscorematchedterritorywidestudy
AT congrongwang earlyorlateadministrationofnirmatrelvirritonavirinmildcovid19patientswithclinicalcomorbiditiesapropensityscorematchedterritorywidestudy